Ashe Gena L 4
4 · Anterix Inc. · Filed Jun 17, 2026
Research Summary
AI-generated summary of this filing
Anterix (ATEX) CLO Ashe Gena Exercises Options, Sells Shares
What Happened
- Ashe Gena, Chief Legal Officer & Corporate Secretary of Anterix (ATEX), exercised two stock options on 2026-06-15 to acquire 29,368 shares total (11,000 at $34.96 and 18,368 at $49.39), representing an exercise cost/value of about $1,291,756.
- A portion of those option shares (4,661 and 10,996 shares) were withheld by the company to cover the exercise price and tax withholding (these withholdings are not open-market sales). Separately, Ashe sold a total of 17,711 shares in open-market transactions on the same date, generating roughly $1,440,049 in proceeds (weighted average prices reported).
- Overall, this was an options exercise combined with partial immediate monetization via share sales — common for executives converting option value to cash.
Key Details
- Transaction date: June 15, 2026; Form 4 filed June 17, 2026 (timely filing).
- Option exercises: 11,000 shares @ $34.96 = $384,560 and 18,368 shares @ $49.39 = $907,196 (codes: M).
- Withheld to cover exercise/taxes (not open-market sales): 4,661 and 10,996 shares (codes: F); values reported ~$384,533 and ~$907,170 respectively.
- Open-market sales: 13,375 shares at a weighted avg $81.04 (prices ranged $81.00–$81.64) = $1,083,890; 4,336 shares at $82.14 = $356,159 (code: S); combined ≈ $1,440,049.
- Vesting: filing notes option shares were fully vested (footnote F5); another footnote (F4) describes a typical three-year vesting schedule for other grants.
- Shares owned after the transactions: not specified in the filing.
- Footnote availability: seller provides a weighted-average sales price and will supply per-trade prices on request (footnote F3).
Context
- These filings show a cashless option exercise (company withheld shares to pay exercise cost/taxes) and concurrent open-market sales. Cashless exercises with partial sell-offs are routine ways for insiders to realize option value; they do not necessarily signal a change in view on the company.
- The filing uses standard Form 4 codes: M = exercise/conversion of derivative, F = withholding to pay exercise/taxes, S = open-market sale.
Insider Transaction Report
Form 4
Anterix Inc.ATEX
Ashe Gena L
Chief Legal Officer & Corp Sec
Transactions
- Exercise/Conversion
Common Stock
2026-06-15$34.96/sh+11,000$384,560→ 24,531 total - Exercise/Conversion
Common Stock
2026-06-15$49.39/sh+18,368$907,196→ 42,899 total - Tax Payment
Common Stock
[F1]2026-06-15$82.50/sh−4,661$384,533→ 38,238 total - Tax Payment
Common Stock
[F2]2026-06-15$82.50/sh−10,996$907,170→ 27,242 total - Sale
Common Stock
[F3]2026-06-15$81.04/sh−13,375$1,083,890→ 13,867 total - Sale
Common Stock
2026-06-15$82.14/sh−4,336$356,159→ 9,531 total - Exercise/Conversion
Stock Option (Right to Buy)
[F4]2026-06-15−11,000→ 42,491 totalExercise: $34.96Exp: 2035-05-20→ Common Stock (11,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F5]2026-06-15−18,368→ 0 totalExercise: $49.39Exp: 2032-05-17→ Common Stock (18,368 underlying)
Footnotes (5)
- [F1]The Reporting Person exercised a stock option to purchase 11,000 shares of the Issuer's Common Stock for $34.96 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 4,661 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock.
- [F2]The Reporting Person exercised a stock option to purchase 18,368 shares of the Issuer's Common Stock for $49.39 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 10,996 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.00 to $81.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F4]The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in two equal annual installments thereafter.
- [F5]The option shares are fully vested.
Signature
/s/ Gena L. Ashe|2026-06-17